Today: 29 April 2026
Standard Chartered share price today: stock edges up on buyback filing, but ShoreCap turns bearish
27 February 2026
2 mins read

Standard Chartered share price today: stock edges up on buyback filing, but ShoreCap turns bearish

London, Feb 27, 2026, 09:44 GMT — Regular session

  • Standard Chartered shares climbed in early London hours after the bank revealed new buyback activity.
  • The filing revealed a purchase of 813,595 shares on Feb. 26, snapped up at a volume-weighted average price of 1,834.17p.
  • Shore Capital dropped its rating on the stock to “sell,” trimming the target price down to 1,490p.

Standard Chartered shares climbed Friday, gaining 0.84% to reach 1,853.50 pence by 0944 GMT, after the bank posted details of fresh share buyback activity. The stock had closed at 1,838 pence previously, Investing.com data showed.

This update’s significance lies in whether the bank delivers real share count reductions after announcing its buyback. Investors are paying close attention. The stock’s sharp pre-earnings rally means the gap between what’s pledged and what’s actually done could sway the price.

Sentiment isn’t all heading in one direction. That early bounce hit resistance after a broker downgrade this week—Shore Capital says the shares have outrun the fundamentals.

Standard Chartered picked up 813,595 ordinary shares on Feb. 26, executing the buyback via J.P. Morgan Securities, as it announced on Feb. 24. The purchase prices ranged from 1,815.50p to 1,848.50p, with the volume-weighted average landing at 1,834.1701p. The bank intends to cancel the shares.

Buybacks act as a direct tool—cutting shares often bumps up earnings per share, assuming everything else stays the same, and tends to broadcast faith in a company’s capital position. The move, though, isn’t without risk: if profits slip or regulators object to capital distributions, the strategy can easily work against a firm.

Earlier this week, Standard Chartered rolled out a $1.5 billion share buyback with its full-year numbers. Chief executive Bill Winters put it this way: “We have increased our full year dividend per share by 65% and are announcing a new share buyback of $1.5 billion.” Standard Chartered Bank

Wealth and cross-border corporate banking have been the bank’s main levers for boosting returns, and shareholder distributions remain a central selling point for investors. But in this market, those draws run up against persistent concerns over earnings volatility—not to mention questions about whether the positives are already baked into the stock.

Shore Capital dropped its rating on the stock to “sell” from “hold”, despite what it called a strong full-year showing from the bank. Analysts warned that “the shares are running ahead of fundamentals.” The target price is now set at 1,490p, about 17% below where shares currently trade. Shore Capital flagged the bank’s updated guidance, which is aiming for a statutory return on tangible equity above 12%—that strips out goodwill and other intangibles. Sharecast

Bulls have a problem: buybacks, by themselves, can’t resolve the underlying dispute over where income growth and costs are headed. If client activity stumbles, or there’s a slip in credit quality or markets revenue, the notion that capital returns can shoulder the load starts to look shaky.

Next, attention shifts to fresh buyback updates and Standard Chartered Bank’s first-quarter numbers due April 30. Investors are looking for a clearer read on 2026 guidance and capital strategy.

Stock Market Today

  • Wheat Prices Surge to New Highs on Tuesday Amid Delayed US Planting
    April 29, 2026, 12:43 AM EDT. The wheat market saw a double-digit rally across Chicago, Kansas City, and Minneapolis exchanges on Tuesday. Chicago Soft Red Winter (SRW) wheat futures gained up to 28 1/4 cents, Kansas City Hard Red Winter (HRW) rose 29 1/2 cents, and Minneapolis spring wheat climbed 21 1/2 cents. U.S. spring wheat planting lags five-year averages by 3 percentage points, with Minnesota 10 points behind. Winter wheat heading is ahead by 13 points but crop condition ratings dropped slightly, with notable declines in several states. Weather forecasts indicate dry spells in key growing regions which may impact yields. Meanwhile, EU soft wheat exports increased by 1.18 million metric tons year-on-year as of April 24. The bullish momentum reflects concerns over crop progress and weather impacts on supply.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 12:44 AM EDT Wheat Prices Surge to New Highs on Tuesday Amid Delayed US Planting April 29, 2026, 12:43 AM EDT. The wheat market saw a double-digit rally across Chicago, Kansas City, and Minneapolis exchanges on Tuesday. Chicago Soft Red Winter (SRW) wheat futures gained up to 28 1/4 cents, Kansas City Hard Red Winter (HRW) rose 29 1/2 cents, and Minneapolis spring wheat climbed 21 1/2 cents. U.S. spring wheat planting lags five-year averages by 3 percentage points, with Minnesota 10 points behind. Winter wheat heading is
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Previous Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch
Next Story

CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch

Go toTop